Patent directory · USPTO A61K / A61P
Patents matching “inhibitor”
2,878 pharma patents match "inhibitor" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 2,878 pharmaceutical patents matching "inhibitor" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 10485803
Pyrimidine compounds as JAK kinase inhibitors
granted -
US 10479786
Protein kinase inhibitors
granted -
US 10478430
Compounds useful as inhibitors of ATR kinase and combination therapies thereof
granted -
US 10479784
Substituted pyrazin-2-amines as inhibitors of ATR kinase
granted -
US 10478435
Use of CRAC channel inhibitors for the treatment of stroke and traumatic brain injury
granted -
US 10479798
Six-membered ring benzo derivatives as DPP-4 inhibitor and use thereof
granted -
US 10471142
Combination therapy using immunoglobulin and C1-Inhibitor
granted -
US 10471061
Galactokinase inhibitors for the treatment and prevention of associated diseases and disorders
granted -
US 10471051
Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cancer
granted -
US 10471055
Methods of treating cancer patients with farnesyltransferase inhibitors
granted -
US 10472387
Inhibitors of glucocorticoid receptor
granted -
US 2019337950
BLOOD-BRAIN BARRIER-PENETRANT DOPAMINE-B-HYDROXYLASE INHIBITORS
granted -
US 10463652
Bach1 inhibitors in combination with Nrf2 activators and pharmaceutical compositions thereof
granted -
US 10463663
Pyridazinone compounds and their use as DAAO inhibitors
granted -
US 10457725
Methods of treating skin cancer by administering a PD-1 inhibitor
granted -
US 10451610
Prediction of response to PARP inhibitors and combinational therapy targeting C-MET and PARP1
granted -
US 10450285
2-benzoylaminobenzamide derivatives as Bcl-3 inhibitors
granted -
US 10448637
Inhibitors of GRB2-associated binding protein 1 (GAB1) and methods of treating cancer using the same
granted -
US 10449182
Sorafenib derivatives as p21 inhibitors
granted -
US 10450572
Androgen receptor variant inhibitors and methods of using
granted -
US 10441586
CRMP2 SUMOylation inhibitors and uses thereof
granted -
US 10442791
DNA-PK inhibitors
granted -
US 10435399
HDAC6 inhibitory heterocyclic compound
granted -
US 10435355
Inhibitors of fatty acid amide hydrolase (FAAH) enzyme with improved oral bioavailability and their use as medicaments
granted